Vertex Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
10.01.25
/
50%
€398.50
Target price
10.01.26
€447.72
Performance (%)
-0.30%
End price
11.01.26
€397.30
Summary
This prediction ended on 11.01.26 with a price of €397.30. The BUY prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc. closed nearly unchanged. Wells_Fargo___Compan has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.088% | -1.088% | -13.820% |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Wells Fargo & Company from $555.00 to $460.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€325.60
06.08.25
06.08.25
€397.62
06.08.26
06.08.26
18.64%
14:19
14:19
Stopped prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€380.75
10.12.25
10.12.25
€442.18
10.12.26
10.12.26
1.46%
14:19
14:19
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€439.95
24.06.24
24.06.24
€516.65
24.06.25
24.06.25
-11.44%
25.06.25
25.06.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€383.95
06.02.24
06.02.24
€502.09
06.02.25
06.02.25
21.15%
07.02.25
07.02.25